VBIO · NASDAQ
Valion Bio (VBIO) Stock Price & Fundamentals
Valion Bio (VBIO) closed at $484.47 on Oct 9, 2026, down 0.26% from the previous close of $485.75.
Share price, past year
1Y +32.08%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $484.47 |
| Sep 30, 2026 | $479.54 |
| Aug 31, 2026 | $466.60 |
| Jul 31, 2026 | $445.98 |
| Jun 30, 2026 | $443.04 |
| May 29, 2026 | $456.39 |
| Apr 30, 2026 | $439.65 |
| Mar 31, 2026 | $412.74 |
| Feb 27, 2026 | $388.84 |
| Jan 30, 2026 | $344.74 |
| Dec 31, 2025 | $367.51 |
| Nov 28, 2025 | $347.25 |
| Oct 31, 2025 | $353.95 |
Key statistics
- Market cap
- $2.01B
- P/E (TTM)
- —
- EPS (TTM)
- —
- Revenue (TTM)
- —
- Net income (TTM)
- −$18.75M
- Shares outstanding
- 4.2M
- Dividend yield
- —
- 52-week range
- $337.21 – $490.35
Valion Bio's market cap is $2.01B, based on a share price of $484.47 and 4.2M shares outstanding as of Jun 30, 2026.
Financials
Valion Bio reported revenue of $780.00K for fiscal 2024, down 33.67% from fiscal 2023.
Valion Bio reported a net loss of $8.88M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $780.00K | −33.7% | −$5.66M | −725.0% | −$19.68 | −$5.73M |
| FY2023ended Dec 31, 2023 | $1.18M | −36.1% | −$8.24M | −701.0% | −$176.80 | −$8.63M |
| FY2022ended Dec 31, 2022 | $1.84M | +46.4% | −$10.10M | −548.7% | −$1,774.15 | −$8.93M |
| FY2021ended Dec 31, 2021 | $1.26M | — | −$8.49M | −675.7% | −$4,132.65 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q3 FY2025ended Sep 30, 2025 | $146.00K | −$2.60M | — |
| Q2 FY2025ended Jun 30, 2025 | $86.00K | −$1.93M | −$2.19 |
| Q1 FY2025ended Mar 31, 2025 | $70.00K | −$1.50M | −$2.52 |
| Q4 FY2024ended Dec 31, 2024 | $180.00K | −$1.48M | $6.75 |
| Q3 FY2024ended Sep 30, 2024 | $126.00K | −$1.43M | −$3.91 |
| Q2 FY2024ended Jun 30, 2024 | $140.00K | — | −$5.37 |
| Q1 FY2024ended Mar 31, 2024 | $334.00K | — | −$17.15 |
| Q4 FY2023ended Dec 31, 2023 | $357.00K | — | $149.05 |
Company profile
- Name
- Valion Bio, Inc.
- Ticker
- VBIO
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1305 E. Houston Street, Building 1, Suite 311, San Antonio, TX 78205
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001787740
Recent SEC filings
- Oct 8, 2026
- Oct 6, 2026
- Oct 1, 2026
- Sep 23, 2026
- Sep 1, 2026
- Aug 27, 2026
- Aug 17, 2026
- Aug 14, 2026
Frequently asked questions
What is Valion Bio's stock price?
Valion Bio (VBIO) closed at $484.47 on Oct 9, 2026, down 0.26% from the previous close of $485.75.
What is Valion Bio's market cap?
Valion Bio's market cap is $2.01B, based on a share price of $484.47 and 4.2M shares outstanding as of Jun 30, 2026.
How much revenue does Valion Bio make?
Valion Bio reported revenue of $780.00K for fiscal 2024, down 33.67% from fiscal 2023.
Does Valion Bio pay a dividend?
Valion Bio's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Valion Bio, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures